Nicholas DiNubile
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicholas DiNubile has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Eric R. Braverman
Department of Clinical Neurology, Path Foundation NY, New York, NY, USA
3 shared publications - Kenneth Blum
Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel 40700, Israel
3 shared publications - Thomas Jh Chen
Department of Occupational Safety and Health , Chang Jung Christian University , Taiwan , ROC
3 shared publications - B. William Downs
Department of Neurosurgery, Weill Cornel School of Medicine, New York, NY, USA
2 shared publications - Roger L. Waite
Department of Nutrigenomics and Personalized Medicine, Lifegen, Inc., San Diego, CA, 92101, USA
2 shared publications - Abdalla Bowirrat
Clinical Neuroscience and Population Genetics, Ziv Government Medical Center, Israel
1 shared publication
Latest Publications
- Open Access
- 10 February 2010
- Published by Springer Nature in Cases Journal
- Vol. 3 (1) , 54
Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE®device therapy: a case series
Approximately 15% (more than 2 million individuals, based on these estimates) of all people with diabetes will develop a lower-extremity ulcer during the course of the disease. Ultimately, between 14% and 20% of patients with lower-extremity diabetic ulcers will require amputation of the affected limb. Analysis of the 1995 Medicare claims revealed that lower-extremity ulcer care accounted for $1.45 billion in Medicare costs. Therapies that promote rapid and complete healing and reduce the need for expensive surgical procedures would impact these costs substantially. One such example is the electrotherapeutic modality utilizing the H-Wave® device therapy and program.
- 10 February 2010
- Published by Springer Nature in Cases Journal
- Vol. 3 (1) , 54
Open AccessHealing enhancement of chronic venous stasis ulcers utilizing H-WAVE®device therapy: a case series
Approximately 15% (more than 2 million individuals, based on these estimates) of all people with diabetes will develop a lower-extremity ulcer during the course of the disease. Ultimately, between 14% and 20% of patients with lower-extremity diabetic ulcers will require amputation of the affected limb. Analysis of the 1995 Medicare claims revealed that lower-extremity ulcer care accounted for $1.45 billion in Medicare costs. Therapies that promote rapid and complete healing and reduce the need for expensive surgical procedures would impact these costs substantially. One such example is the electrotherapeutic modality utilizing the H-Wave® device therapy and program.
- 1 November 2009
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 121 (6) , 176-196
Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART)
Background and Hypothesis: It is well known that after prolonged abstinence, individuals who use their drug of choice experience a powerful euphoria that often precipitates relapse. While a biologi...
- 1 November 2009
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 121 (6) , 176-196
Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART)
Background and Hypothesis: It is well known that after prolonged abstinence, individuals who use their drug of choice experience a powerful euphoria that often precipitates relapse. While a biologi...
- Open Access
- 29 October 2009
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 10 (1) , 132
Repetitive H-Wave® device stimulation and program induces significant increases in the range of motion of post operative rotator cuff reconstruction in a double-blinded randomized placebo controlled human study
Albeit other prospective randomized controlled clinical trials on H-Wave Device Stimulation (HWDS), this is the first randomized double-blind Placebo controlled prospective study that assessed the effects of HWDS on range of motion and strength testing in patients who underwent rotator cuff reconstruction.
- 29 October 2009
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 10 (1) , 132
Open AccessRepetitive H-Wave® device stimulation and program induces significant increases in the range of motion of post operative rotator cuff reconstruction in a double-blinded randomized placebo controlled human study
Albeit other prospective randomized controlled clinical trials on H-Wave Device Stimulation (HWDS), this is the first randomized double-blind Placebo controlled prospective study that assessed the effects of HWDS on range of motion and strength testing in patients who underwent rotator cuff reconstruction.